Actually, it is not that uncommon. One in sixty-seven people in Australia will be diagnosed with it by the age of 85. And the prognosis is terrible - only 12% alive after five years. I am a former holder. As chance would have it, I sold just before the CR was announced (at a loss). Of course, I could have bought back in in time to participate in the CR and get the options. I decided not to as I wondered whether other forms of therapy might be developed to supersede Oncosil's treatment (monoclonal antibodies ? - I know nothing). However , I am keeping an eye on Oncosil in case anything positive happens.
OSL Price at posting:
1.1¢ Sentiment: Hold Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)